1. Home
  2. EPAM vs ALGN Comparison

EPAM vs ALGN Comparison

Compare EPAM & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EPAM Systems Inc.

EPAM

EPAM Systems Inc.

HOLD

Current Price

$145.74

Market Cap

11.5B

Sector

Technology

ML Signal

HOLD

Logo Align Technology Inc.

ALGN

Align Technology Inc.

HOLD

Current Price

$173.43

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPAM
ALGN
Founded
1993
1997
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5B
12.0B
IPO Year
2011
2000

Fundamental Metrics

Financial Performance
Metric
EPAM
ALGN
Price
$145.74
$173.43
Analyst Decision
Buy
Buy
Analyst Count
14
11
Target Price
$201.07
$192.40
AVG Volume (30 Days)
1.4M
1.2M
Earning Date
05-22-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
0.53
EPS
6.72
5.65
Revenue
$1,450,448,000.00
$387,126,000.00
Revenue This Year
$8.92
$5.85
Revenue Next Year
$8.87
$4.45
P/E Ratio
$21.60
$31.14
Revenue Growth
25.02
23.95
52 Week Low
$125.57
$122.00
52 Week High
$222.53
$208.31

Technical Indicators

Market Signals
Indicator
EPAM
ALGN
Relative Strength Index (RSI) 37.30 42.11
Support Level $125.57 $170.63
Resistance Level $165.67 $174.67
Average True Range (ATR) 7.19 5.75
MACD 1.66 -2.37
Stochastic Oscillator 44.01 23.32

Price Performance

Historical Comparison
EPAM
ALGN

About EPAM EPAM Systems Inc.

EPAM Systems is a global IT services firm with a focus on platform engineering, software development, and consulting services. The company used to host large engineer bases in Ukraine, Belarus, and Russia, but it now delivers from various locations across different continents. EPAM's largest market is North America, which represents approximately 60% of revenue.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: